145 related articles for article (PubMed ID: 23788664)
1. Isolation of αL I domain mutants mediating firm cell adhesion using a novel flow-based sorting method.
Pepper LR; Parthasarathy R; Robbins GP; Dang NN; Hammer DA; Boder ET
Protein Eng Des Sel; 2013 Aug; 26(8):515-21. PubMed ID: 23788664
[TBL] [Abstract][Full Text] [Related]
2. Rolling adhesion of alphaL I domain mutants decorrelated from binding affinity.
Pepper LR; Hammer DA; Boder ET
J Mol Biol; 2006 Jun; 360(1):37-44. PubMed ID: 16813834
[TBL] [Abstract][Full Text] [Related]
3. Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state.
Salas A; Shimaoka M; Phan U; Kim M; Springer TA
J Biol Chem; 2006 Apr; 281(16):10876-82. PubMed ID: 16505487
[TBL] [Abstract][Full Text] [Related]
4. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1.
Salas A; Shimaoka M; Chen S; Carman CV; Springer T
J Biol Chem; 2002 Dec; 277(52):50255-62. PubMed ID: 12368274
[TBL] [Abstract][Full Text] [Related]
5. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow.
Eniola AO; Krasik EF; Smith LA; Song G; Hammer DA
Biophys J; 2005 Nov; 89(5):3577-88. PubMed ID: 16100282
[TBL] [Abstract][Full Text] [Related]
6. Importance of force linkage in mechanochemistry of adhesion receptors.
Astrof NS; Salas A; Shimaoka M; Chen J; Springer TA
Biochemistry; 2006 Dec; 45(50):15020-8. PubMed ID: 17154539
[TBL] [Abstract][Full Text] [Related]
7. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment.
Sigal A; Bleijs DA; Grabovsky V; van Vliet SJ; Dwir O; Figdor CG; van Kooyk Y; Alon R
J Immunol; 2000 Jul; 165(1):442-52. PubMed ID: 10861083
[TBL] [Abstract][Full Text] [Related]
8. Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction.
Salas A; Shimaoka M; Kogan AN; Harwood C; von Andrian UH; Springer TA
Immunity; 2004 Apr; 20(4):393-406. PubMed ID: 15084269
[TBL] [Abstract][Full Text] [Related]
9. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo.
Shimaoka M; Lu C; Palframan RT; von Andrian UH; McCormack A; Takagi J; Springer TA
Proc Natl Acad Sci U S A; 2001 May; 98(11):6009-14. PubMed ID: 11353828
[TBL] [Abstract][Full Text] [Related]
10. An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond.
Lu C; Shimaoka M; Ferzly M; Oxvig C; Takagi J; Springer TA
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2387-92. PubMed ID: 11226249
[TBL] [Abstract][Full Text] [Related]
11. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
[TBL] [Abstract][Full Text] [Related]
12. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1. Molecular insights into integrin inhibition.
Welzenbach K; Hommel U; Weitz-Schmidt G
J Biol Chem; 2002 Mar; 277(12):10590-8. PubMed ID: 11781316
[TBL] [Abstract][Full Text] [Related]
14. The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7.
Chen J; Takagi J; Xie C; Xiao T; Luo BH; Springer TA
J Biol Chem; 2004 Dec; 279(53):55556-61. PubMed ID: 15448154
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the integrin alphaLbeta2 transmembrane domain interface by beta2 Thr-686 mutation activates alphaLbeta2 and promotes micro-clustering of the alphaL subunits.
Vararattanavech A; Lin X; Torres J; Tan SM
J Biol Chem; 2009 Jan; 284(5):3239-3249. PubMed ID: 19029120
[TBL] [Abstract][Full Text] [Related]
16. Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion.
Song G; Lazar GA; Kortemme T; Shimaoka M; Desjarlais JR; Baker D; Springer TA
J Biol Chem; 2006 Feb; 281(8):5042-9. PubMed ID: 16354667
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of monoclonal antibody to integrin alphaL beta2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding.
Tang RH; Tng E; Law SK; Tan SM
J Biol Chem; 2005 Aug; 280(32):29208-16. PubMed ID: 15958383
[TBL] [Abstract][Full Text] [Related]
18. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
[TBL] [Abstract][Full Text] [Related]
19. A pivotal role for a conserved bulky residue at the α1-helix of the αI integrin domain in ligand binding.
Wang Z; Thinn AMM; Zhu J
J Biol Chem; 2017 Dec; 292(50):20756-20768. PubMed ID: 29079572
[TBL] [Abstract][Full Text] [Related]
20. The integrin αL leg region controls the Mg/EGTA mediated activation of LFA-1.
Guan S; Cheng M; Law SK
Biochem Biophys Res Commun; 2015 Mar; 458(2):251-5. PubMed ID: 25640842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
